Interactions of prostanoids with the platelet activating factors

This publication has 19 references indexed in Scilit:

• Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion
  European Journal of Pharmacology, 1989
• Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart
  Journal of Molecular and Cellular Cardiology, 1988
• The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition
  Inflammation Research, 1987
• Comparison of cardiac and hemodynamic effects of plateletactivating factor-acether and leukotriene D4 in anesthetized dogs
  Basic Research in Cardiology, 1987
• Direct effects of platelet activating factor (PAF) on cardiac function in isolated guinea pig heart
  Drug Development Research, 1987
• Effect of Platelet-Activating Factor (PAF) on Human Cardiac Muscle
  International Archives of Allergy and Immunology, 1986
• Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.
  Journal of Clinical Investigation, 1985
• Neutrophil degranulation: Evidence pertaining to its mediation by the combined effects of leukotriene B₄, platelet‐activating factor, and 5‐HETE
  Journal of Cellular Physiology, 1985
• Cooperative effects of 1-O-alkyl-2-O-acetyl--glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets
  Thrombosis Research, 1984
• The effects of oral nafazatrom (=BAYg 6575) on canine coronary artery thrombosis and myocardial ischemia
  Basic Research in Cardiology, 1983